Literature DB >> 14510093

Patent ductus arteriosus in fetal valproate syndrome.

P Anoop, C K Sasidharan.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14510093     DOI: 10.1007/bf02724264

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  7 in total

1.  Teratogenicity of valproic acid.

Authors:  B Dalens; E J Raynaud; J Gaulme
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

2.  Possible teratogenicity of valproic acid.

Authors:  M R Gomez
Journal:  J Pediatr       Date:  1981-03       Impact factor: 4.406

Review 3.  Teratogen update: valproic acid.

Authors:  E J Lammer; L E Sever; G P Oakley
Journal:  Teratology       Date:  1987-06

4.  Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.

Authors:  F Ebbesen; A Joergensen; E Hoseth; P H Kaad; M Moeller; V Holsteen; M Rix
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

5.  The fetal valproate syndrome.

Authors:  J H DiLiberti; P A Farndon; N R Dennis; C J Curry
Journal:  Am J Med Genet       Date:  1984-11

6.  Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

Authors:  E Thisted; F Ebbesen
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

Review 7.  Verification of the fetal valproate syndrome phenotype.

Authors:  H H Ardinger; J F Atkin; R D Blackston; L J Elsas; S K Clarren; S Livingstone; D B Flannery; J M Pellock; M J Harrod; E J Lammer
Journal:  Am J Med Genet       Date:  1988-01
  7 in total
  1 in total

1.  Familial clustering of congenital deafness, patent ductus arteriosus, Eisenmenger complex, and differential cyanosis: A case report.

Authors:  Ting-Wei Lin; Chih-Wei Tseng; Chi-Yao Huang; Kuo-Yang Wang; Kae-Woei Liang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.